(marketscreener.com) WASHINGTON, Dec. 9, 2021 /PRNewswire/ -- BrainQ today announced that the first patient has been enrolled at MedStar National Rehabilitation Hospital in its pivotal, randomized, double-blind, multicenter trial, EMAGINE . The trial is evaluating its frequency-tuned electromagnetic field treatment in facilitating recovery in individuals with...https://www.marketscreener.com/news/latest/First-Patient-Enrolled-in-BrainQ-s-Pivotal-Trial-EMAGINE-trade-for-Frequency-Tuned-Electromagneti--37273629/?utm_medium=RSS&utm_content=20211209